Physician profile
Suraj Rao
NPI 1336467018
$11,659.96
in general payments reported to CMS, 2019-2025
42 companies · $3,158 in 2025
The $3,158 reported for 2025 was more than what 76% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,513 · 2020: $362 · 2021: $1,348 · 2022: $1,591 · 2023: $1,216 · 2024: $1,471 · 2025: $3,158.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,826 · Education: $19.62.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,825.97 |
| Education | $19.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,088.66 | 2019-2025 | Navitor |
| E.R. Squibb & Sons, L.L.C. | $979.98 | 2020-2025 | Eliquis, Camzyos, Sotyktu |
| Medtronic, INC. | $969.83 | 2021-2025 | Symplicity G3, Micra, Aurora Ev-Icd Mri Surescan |
| Novartis Pharmaceuticals Corporation | $817.41 | 2021-2025 | |
| Cvrx, INC. | $796.09 | 2022-2025 | Barostim Neo System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $725.45 | 2019-2025 | Lifevest |
| Pfizer INC. | $609.65 | 2019-2025 | |
| Boston Scientific Corporation | $597.30 | 2019-2025 | Watchman Flx, Comet |
| Astrazeneca Pharmaceuticals LP | $528.74 | 2019-2025 | Farxiga, Brilinta |
| Edwards Lifesciences Corporation | $430.17 | 2019-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Amgen INC. | $406.72 | 2019-2025 | Repatha, Repatha |
| Philips North America LLC | $243.02 | 2022-2025 | Ambulatory Monitoring & Diagnostics Undivided, Ecc Solutions |
| Abiomed | $236.73 | 2021-2025 | Impella |
| Merck Sharp & Dohme LLC | $234.83 | 2022-2025 | Verquvo |
| Medtronic Vascular, INC. | $201.17 | 2019 |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $185.85 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $168.31 | 2021-2024 | Jardiance |
| Vital Connect, INC | $142.73 | 2022-2024 | Vitalpatch Rtm |
| Akcea Therapeutics, INC. | $134.40 | 2019 | |
| Janssen Pharmaceuticals, INC | $129.30 | 2020-2024 | Xarelto |
| Atricure, INC. | $128.07 | 2022-2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Amarin Pharma, INC. | $123.44 | 2019-2022 | |
| Cook Medical LLC | $114.94 | 2019-2025 | Cook |
| Lexicon Pharmaceuticals, INC. | $106.50 | 2023-2024 | Inpefa |
| Actelion Pharmaceuticals US, INC. | $66.56 | 2021-2024 | Opsumit |
| Baxter Healthcare | $45.39 | 2023-2024 | Hillrom - Carnation Ambulatory Monitor, Hillrom - Cardiac Ambulatory Monitor |
| Biosense Webster, INC. | $44.94 | 2022 | |
| Kiniksa Pharmaceuticals International, Plc | $43.29 | 2024 | Arcalyst |
| Cardiva Medical, INC. | $40.22 | 2024 | Savvywire |
| Kiniksa Pharmaceuticals, LTD. | $38.60 | 2023 | Arcalyst |
| Bayer Healthcare Pharmaceuticals INC. | $36.63 | 2024 | |
| Astellas Pharma US INC | $34.66 | 2019 | |
| Siemens Medical Solutions USA, INC. | $34.47 | 2024 | Artis Icono Biplane |
| Impulse Dynamics (USA) INC. | $27.64 | 2023 | Optimizer |
| Bardy Diagnostics, INC. | $25.82 | 2022 | |
| Sanofi-Aventis U.S. LLC | $22.80 | 2023 | |
| Scpharmaceuticals INC. | $19.80 | 2025 | |
| Medicomp INC | $19.78 | 2022 | |
| Elutia, INC. | $19.51 | 2024 | Ecm Patch,Pouch |
| Esperion Therapeutics, INC. | $15.14 | 2024 | Nexletol |
| Cardiovascular Systems INC. | $13.68 | 2019 | |
| Angiodynamics, INC. | $11.74 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Suraj Rao listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.